Cvs Health Corp (CVS) Shareholder Washington Trust Company Decreased Stake

Adjust Comment Print

About 1.32M shares traded. It has outperformed by 16.91% the S&P500. Arcadia Investment Management Corp MI boosted its stake in shares of CVS Health by 119.6% during the 3rd quarter. Analysts anticipate that CVS Health Corp will post $5.86 earnings per share for the current fiscal year.

Profitability Ratios (ROE, ROA, ROI): Looking into the profitability ratios of CVS stock, an investor will find its ROE, ROA, ROI standing at 18.8%, 7.1% and 12.2%, respectively. The institutional investor held 1.99M shares of the medical and nursing services company at the end of 2017Q4, valued at $144.10M, up from 1.54M at the end of the previous reported quarter.

In total 14 analysts cover CVS Health (NYSE:CVS). Washington Trust Company has risen its stake in Ishares Tr (AGG) and also increased its holding in Ishares Tr (GVI) by 42,902 shares in the quarter, for a total of 152,144 shares. If we take a longer approach, shares have been trading 5.47% away from the 200-day moving average.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. CVS underperformed by 34.36% the S&P 500.

In other CVS Health news, EVP Helena Foulkes sold 19,965 shares of CVS Health stock in a transaction that occurred on Friday, February 16th.

Among 29 analysts covering Target Corporation (NYSE:TGT), 11 have Buy rating, 3 Sell and 15 Hold. The positive are 71%.

Zillow (ZG) Price Target Raised to $43.00
Looking at some alternate time periods, the 12 month price index is 1.43301, the 24 month is 2.17168, and the 36 month is 1.56369. In Play Stocks are volatile enough to produce good risk and reward trading opportunities for both bull and bear traders intraday.


Target Price/Analysts Mean Suggestion: Mostly, a price target is an individual analyst's expectation on the future price of a security, usually a stock. On Friday, October 27 the stock rating was maintained by Robert W. Baird with "Hold". The firm has "Buy" rating given on Monday, March 26 by Oppenheimer. On Tuesday, November 7 the firm has "Hold" rating given by Jefferies. On Wednesday, January 17 the stock rating was maintained by Robert W. Baird with "Hold". Robert W. Baird initiated it with "Outperform" rating and $108 target in Friday, January 22 report. On Monday, November 13 the rating was maintained by Citigroup with "Neutral". In Friday, November 10 report Needham upgraded the stock to "Buy" rating.

Taking notice on volatility measures, CVS Health Corporation has noticeable recent volatility credentials; price volatility of stock was 3.47% for a recent week and 2.92% for a month. The company has a market capitalization of $64,351.77, a PE ratio of 11.20, a PEG ratio of 1.05 and a beta of 1.05. The pharmacy operator reported $1.92 EPS for the quarter, topping analysts' consensus estimates of $1.88 by $0.04.

Big Money Sentiment decreased to 0.72 in Q4 2017. That's change of 0.16, from 2017Q3's 0.88. It worsened, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds bought positions and 380 increased positions. The institutional investor held 233,864 shares of the major banks company at the end of 2017Q4, valued at $6.90 million, down from 252,693 at the end of the previous reported quarter. Moreover, Umb Bancorporation N A Mo has 0.25% invested in CVS Health Corporation (NYSE:CVS). Liquidity allows an investor to enter and exit a stock at a good price (i.e. tight spreads, or the difference between the bid and ask price of a stock, and low slippage, or the difference between the predictable price of a trade and the actual price).

Therefore, the stated figure displays a quarterly performance of 2.81%, bringing six-month performance to -18.07% and year to date performance of -0.68%. Westwood Group Incorporated reported 1.19M shares. The stock of CVS Health Corporation (NYSE:CVS) has "Buy" rating given on Tuesday, January 30 by Needham. Columbia Asset Management reported 6,846 shares. Fernwood Investment Management Ltd Liability owns 1.82% invested in CVS Health Corporation (NYSE:CVS) for 46,873 shares. Comerica Bancshares reported 60,377 shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh has invested 0.25% in CVS Health Corporation (NYSE:CVS). Highstreet Asset Mngmt holds 0.1% or 22,315 shs. Bontempo Ohly Capital Mgmt LLC grew its position in shares of CVS Health by 0.5% during the 2nd quarter. Gillespie Robinson And Grimm invested in 303,406 shares. Cadence Comml Bank Na owns 12,697 shs for 0.34% of their capital. The insider now directly owns 160,194 shares worth $10,588,823.

Parnassus Investments increased Wells Fargo & Co. It also upped Motorola Solutions Inc. Following the completion of the sale, the executive vice president now directly owns 65,072 shares in the company, valued at approximately $4,622,714.88.

Analysts await General Electric Company (NYSE:GE) to report earnings on April, 20 before the open. (NASDAQ:AAPL) to report earnings on May, 1 after the close. As a result, the company has Earnings per Share (EPS) growth of 7.83% for the coming year. MD's profit will be $75.61M for 16.33 P/E if the $0.81 EPS becomes a reality. Robeco Institutional Asset Mgmt Bv owns 684,496 shares or 0.26% of their USA portfolio. The firm has "Buy" rating given on Tuesday, June 6 by Jefferies. Its down 0.20, from 1.28 in 2017Q3. It improved, as 50 investors sold AAPL shares while 1023 reduced holdings. 151 funds opened positions while 383 raised stakes. Burney Co accumulated 129,903 shares. Point72 Asia (Hong Kong) Limited invested 0.02% in Penske Automotive Group, Inc. Gotham Asset Mngmt Ltd Liability Corporation invested in 1% or 951,796 shares. Da Davidson And Company holds 0.78% or 514,609 shares. Meritage Management invested 3.09% of its portfolio in Apple Inc. Rockefeller holds 1.8% or 1.57M shares in its portfolio. The insider Meaney William L sold 24,137 shares worth $774,371. The Pennsylvania-based Orrstown Financial Services has invested 1.99% in Apple Inc. Great Lakes Advsr Limited accumulated 381,653 shs or 0.61% of the stock. The Stock has market cap of $65651.32M and relative volume of 0.68.

Comments